Genotype Hepatitis B Virus Among Intravenous Drug Users with Occult Hepatitis B Infection in Surabaya, Indonesia

Author(s):  
Lina Lukitasari ◽  
Lilik Herawati ◽  
Edhi Rianto ◽  
Indri Safitri ◽  
Retno Handajani ◽  
...  
2007 ◽  
Vol 79 (11) ◽  
pp. 1674-1678 ◽  
Author(s):  
Chih-Lin Lin ◽  
Chun-Jen Liu ◽  
Pei-Jer Chen ◽  
Ming-Yang Lai ◽  
Ding-Shinn Chen ◽  
...  

2004 ◽  
Vol 74 (4) ◽  
pp. 536-542 ◽  
Author(s):  
Bing-Fang Chen ◽  
Pei-Jer Chen ◽  
Guey-Mei Jow ◽  
Erwin Sablon ◽  
Chun-Jen Liu ◽  
...  

Author(s):  
Rahil Nahid Samiei ◽  
Somayeh Shokri ◽  
Shahab Mahmoudvand ◽  
Manoochehr Makvandi ◽  
Heshmatollah Shahbazian ◽  
...  

Hepatitis B virus is a major public health impasse all over the world. Recently a new form of hepatitis B infection named Occult hepatitis B Infection (OBI) has appeared globally. The OBI is defined as the presence of HBV DNA in the liver and/or blood in the absence of detectable serum HBsAg with/without anti-HBc or anti-HBs. The prevalence of OBI has been reported in hemodialysis (HD) patients in different regions of the world. Thus, this study investigated the prevalence of OBI among HD patients. The cross-sectional study was carried out on 84 HD patients. These sera were checked for HBsAg, HBc-IgG assessment using Enzyme linked immunosorbent assay. The DNA was extracted from the sera samples and tested for HBVDNA detection using Nested Polymerase Chain Reaction (Nested PCR). The liver function tests including serum alanine aminotransferase and aspartate aminotransferase levels were carried out for all the HD individuals. 52/84(61.9%) of HD were males and 32/84 (38.1%) were females. The patient’s age ranged from 25 to 64 with a mean age of 52.4±15.2 years. HBsAg and HBc-IgG were detected in 1(1.1%) female. 2 (2.4%; a female and a male) patients were positive for HBsAg. 14/84 (16.7%; 6 female and 8 male) HD patients were positive for anti-HBc but negative for HBsAg, among them 4(28.6%; 2 female and 2 male) cases were positive for HBV DNA, indicating the presence of OBI in HD patients. Even distribution of OBI among the HD was found in 2(2.36%) male and 2(2.36%) female (P>.0.05). In the present study the moderate rate of 4.76% OBI has been observed in HD patients. The prevalence of seropositive OBI among the gender was 2(2.36%) male and 2(2.36%) female. The seronegative OBI have not been detected in the present study but requires further investigation. In this study the affliction of OBI in HD patients is not clear.


2001 ◽  
Vol 13 (11) ◽  
pp. 1347-1354 ◽  
Author(s):  
M. Santolamazza ◽  
M. Delle Monache ◽  
A. Alvino ◽  
M. Bacosi ◽  
S. D'Innocenzo ◽  
...  

1991 ◽  
Vol 163 (4) ◽  
pp. 923-923 ◽  
Author(s):  
P. Mezzelani ◽  
L. Venturini ◽  
G. Turrina ◽  
F. Lugoboni ◽  
D. C. Des Jarlais

2021 ◽  
Author(s):  
Paniz Shirmast ◽  
Mahdi Abedinzade Shahri ◽  
Salar Pashangzadeh ◽  
Hessam Mirshahabi ◽  
Elham Samadi ◽  
...  

Aim: Occult hepatitis B infection (OBI) is life threatening and has a high mortality rate despite applying antiviral treatments in cancer patients. This study aimed to investigate the prevalence of OBI in patients undergoing chemotherapy in Iran. Materials & methods: A total of 342 patients undergoing chemotherapy were enrolled. OBI detection in anti-HBc positive individuals was conducted using nested-PCR. Results: Among 342 subjects, 103 (30.1%) were positive for anti-HBc. Fifteen (14.6%) cases of 103 anti-HBc positive samples were also positive for HBsAg. Overall, HBV DNA was positive in three (3.4%) of 88 anti-HBc subjects. Conclusion: Our results indicated that OBI might occur in almost one in 25 anti-HBc-positive patients undergoing chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document